✦ LIBER ✦

“Is it cost-effective to use procalcitonin to predict outcome in community-acquired pneumonia in the ED?” Response to the authors

✍ Scribed by Park, Jeong Ho; Choi, Seung Pill; Wee, Jung Hee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is it cost-effective to use procalcitoni

✍ Su, Shih-Yang; Chao, Chien-Ming; Lai, Chih-Cheng 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Is it Possible to Improve the Management

✍ Agustín Julián-Jiménez; María José Palomo de los Reyes; Natividad Laín-Terés 📂 Article 📅 2010 🏛 Elsevier Science 🌐 Spanish ⚖ 64 KB

The role of biomarkers in community-acqu

✍ Jean-Paul Mira,Adeline Max,Pierre-Regis Burgel 📂 Article 📅 2008 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 216 KB

Is it possible to distinguish between at

✍ Naoyuki Miyashita; Hiroshi Fukano; Koichiro Yoshida; Yoshihito Niki; Toshiharu M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Pneumonia severity index compared to CUR

✍ Alavi-Moghaddam, Mostafa; Bakhshi, Hooman; Rezaei, Bareza; Khashayar, Patricia 📂 Article 📅 2013 🏛 SciELO 🌐 English ⚖ 432 KB

AR3 MOXIFLOXACIN IV/PO MONOTHERAPY IS CO

✍ M Drummond; D Becker; M Hux; J Chancellor; I Duprat-Lomon; PP Sagnier 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB